QA: Oncternal Therapeutics Inc in us_pharma/2015

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001260990_2016_Oncternal_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001260990, Oncternal Therapeutics Inc

  xvar xval
0 AssetsCurrent 31,889,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 5,000
3 remainder_Assets 137,000
4 LiabilitiesCurrent 30,172,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 8,500,264
9 ResearchAndDevelopmentExpense 10,933,724
10 remainder_Expenses 939,603
11 remainder_Revenues 0
12 remainder_NetIncome -36,827
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 32,031,000
1 Liabilities 30,172,000
2 Expenses 20,373,591
3 Revenues 0
4 StockholdersEquity 1,859,000
5 NetIncome -20,410,418
6 ComprehensiveNetIncome -20,410,418
7 BaseVar 41,306,709
8 EconomicCapitalRatiobeforeLimitedLiability -0.526
9 EconomicCapitalRatio 1.38

Edgar->Model Mapping

Feature Distribution

Change over Time